Report cover image

Global Dermatology OTC Medications Competitive Landscape Professional Research Report 2025

Publisher DIResearch
Published Jan 23, 2025
Length 170 Pages
SKU # DIR19531908

Description

Global Dermatology OTC Medications Competitive Landscape Professional Research Report 2025



Research Summary

Dermatology over-the-counter (OTC) medications are non-prescription pharmaceutical products available to consumers without a doctor＇s prescription, specifically formulated to address a variety of common skin concerns and conditions. These medications include creams, ointments, lotions, gels, and foams that can treat issues such as acne, eczema, psoriasis, fungal infections, and minor irritations. Dermatology OTC medications often contain active ingredients like benzoyl peroxide, salicylic acid, hydrocortisone, or antifungal agents that work to alleviate symptoms and promote skin health. While generally considered safe for self-use, it＇s important for individuals to carefully read and follow the product instructions and consult a healthcare professional if their skin condition does not improve or worsens.

According to DIResearch's in-depth investigation and research, the global Dermatology OTC Medications market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Dermatology OTC Medications include Bayer, GSK, Teva, Johnson & Johnson, Novartis, Mylan, Sun Pharmaceutical, Aurobindo, Galderma, CR SANJIU, Bausch Health, Lupin, Dr. Reddy＇s, Cipla, Qilu Pharmaceutical, Almirall, Lingrui etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Dermatology OTC Medications. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Dermatology OTC Medications market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Dermatology OTC Medications market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Dermatology OTC Medications industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Dermatology OTC Medications Include:

Bayer

GSK

Teva

Johnson & Johnson

Novartis

Mylan

Sun Pharmaceutical

Aurobindo

Galderma

CR SANJIU

Bausch Health

Lupin

Dr. Reddy＇s

Cipla

Qilu Pharmaceutical

Almirall

Lingrui

Dermatology OTC Medications Product Segment Include:

Topical Drug

Oral Drug

Dermatology OTC Medications Product Application Include:

Psoriasis

Skin Infections

Acne

Dermatitis

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Dermatology OTC Medications Industry PESTEL Analysis

Chapter 3: Global Dermatology OTC Medications Industry Porter’s Five Forces Analysis

Chapter 4: Global Dermatology OTC Medications Major Regional Market Size and Forecast Analysis

Chapter 5: Global Dermatology OTC Medications Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Dermatology OTC Medications Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Dermatology OTC Medications Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Dermatology OTC Medications Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Dermatology OTC Medications Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Dermatology OTC Medications Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Dermatology OTC Medications Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Dermatology OTC Medications Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

170 Pages
1 Dermatology OTC Medications Market Overview
1.1 Product Definition and Statistical Scope
1.2 Dermatology OTC Medications Product by Type
1.2.1 Topical Drug
1.2.2 Oral Drug
1.3 Dermatology OTC Medications Product by Application
1.3.1 Psoriasis
1.3.2 Skin Infections
1.3.3 Acne
1.3.4 Dermatitis
1.3.5 Others
1.4 Global Dermatology OTC Medications Market Size Analysis (2020-2032)
1.5 Dermatology OTC Medications Market Development Status and Trends
1.5.1 Dermatology OTC Medications Industry Development Status Analysis
1.5.2 Dermatology OTC Medications Industry Development Trends Analysis
2 Dermatology OTC Medications Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Dermatology OTC Medications Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Dermatology OTC Medications Market Analysis by Regions
4.1 Dermatology OTC Medications Overall Market: 2024 VS 2025 VS 2032
4.2 Global Dermatology OTC Medications Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Dermatology OTC Medications Revenue and Market Share by Region (2020-2025)
4.2.2 Global Dermatology OTC Medications Revenue Forecast by Region (2026-2032)
5 Global Dermatology OTC Medications Market Size by Type and Application
5.1 Global Dermatology OTC Medications Market Size by Type (2020-2032)
5.2 Global Dermatology OTC Medications Market Size by Application (2020-2032)
6 North America
6.1 North America Dermatology OTC Medications Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Manufacturers Analysis
6.3 North America Dermatology OTC Medications Market Size by Type
6.4 North America Dermatology OTC Medications Market Size by Application
6.5 North America Dermatology OTC Medications Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Dermatology OTC Medications Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Dermatology OTC Medications Market Size by Type
7.4 Europe Dermatology OTC Medications Market Size by Application
7.5 Europe Dermatology OTC Medications Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Dermatology OTC Medications Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Manufacturers Analysis
8.3 China Dermatology OTC Medications Market Size by Type
8.4 China Dermatology OTC Medications Market Size by Application
9 APAC (excl. China)
9.1 APAC (excl. China) Dermatology OTC Medications Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Dermatology OTC Medications Market Size by Type
9.4 APAC (excl. China) Dermatology OTC Medications Market Size by Application
9.5 APAC (excl. China) Dermatology OTC Medications Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 Latin America
10.1 Latin America Dermatology OTC Medications Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Dermatology OTC Medications Market Size by Type
10.4 Latin America Dermatology OTC Medications Market Size by Application
10.5 Latin America Dermatology OTC Medications Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Dermatology OTC Medications Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Dermatology OTC Medications Market Size by Type
11.4 Middle East & Africa Dermatology OTC Medications Market Size by Application
11.5 Middle East & Africa Dermatology OTC Medications Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global Dermatology OTC Medications Market Revenue by Key Manufacturers (2021-2025)
12.2 Dermatology OTC Medications Competitive Landscape Analysis and Market Dynamic
12.2.1 Dermatology OTC Medications Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Bayer
13.1.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Bayer Dermatology OTC Medications Product Portfolio
13.1.3 Bayer Dermatology OTC Medications Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.2 GSK
13.2.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 GSK Dermatology OTC Medications Product Portfolio
13.2.3 GSK Dermatology OTC Medications Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.3 Teva
13.3.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Teva Dermatology OTC Medications Product Portfolio
13.3.3 Teva Dermatology OTC Medications Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Johnson & Johnson Dermatology OTC Medications Product Portfolio
13.4.3 Johnson & Johnson Dermatology OTC Medications Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.5 Novartis
13.5.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Novartis Dermatology OTC Medications Product Portfolio
13.5.3 Novartis Dermatology OTC Medications Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.6 Mylan
13.6.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Mylan Dermatology OTC Medications Product Portfolio
13.6.3 Mylan Dermatology OTC Medications Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.7 Sun Pharmaceutical
13.7.1 Sun Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Sun Pharmaceutical Dermatology OTC Medications Product Portfolio
13.7.3 Sun Pharmaceutical Dermatology OTC Medications Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.8 Aurobindo
13.8.1 Aurobindo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Aurobindo Dermatology OTC Medications Product Portfolio
13.8.3 Aurobindo Dermatology OTC Medications Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.9 Galderma
13.9.1 Galderma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Galderma Dermatology OTC Medications Product Portfolio
13.9.3 Galderma Dermatology OTC Medications Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.10 CR SANJIU
13.10.1 CR SANJIU Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 CR SANJIU Dermatology OTC Medications Product Portfolio
13.10.3 CR SANJIU Dermatology OTC Medications Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.11 Bausch Health
13.11.1 Bausch Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 Bausch Health Dermatology OTC Medications Product Portfolio
13.11.3 Bausch Health Dermatology OTC Medications Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.12 Lupin
13.12.1 Lupin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.12.2 Lupin Dermatology OTC Medications Product Portfolio
13.12.3 Lupin Dermatology OTC Medications Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.13 Dr. Reddy＇s
13.13.1 Dr. Reddy＇s Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.13.2 Dr. Reddy＇s Dermatology OTC Medications Product Portfolio
13.13.3 Dr. Reddy＇s Dermatology OTC Medications Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.14 Cipla
13.14.1 Cipla Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.14.2 Cipla Dermatology OTC Medications Product Portfolio
13.14.3 Cipla Dermatology OTC Medications Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.15 Qilu Pharmaceutical
13.15.1 Qilu Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.15.2 Qilu Pharmaceutical Dermatology OTC Medications Product Portfolio
13.15.3 Qilu Pharmaceutical Dermatology OTC Medications Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.16 Almirall
13.16.1 Almirall Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.16.2 Almirall Dermatology OTC Medications Product Portfolio
13.16.3 Almirall Dermatology OTC Medications Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.17 Lingrui
13.17.1 Lingrui Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.17.2 Lingrui Dermatology OTC Medications Product Portfolio
13.17.3 Lingrui Dermatology OTC Medications Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 Industry Chain Analysis
14.1 Dermatology OTC Medications Industry Chain Analysis
14.2 Dermatology OTC Medications Industry Raw Material and Suppliers Analysis
14.2.1 Dermatology OTC Medications Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Dermatology OTC Medications Typical Downstream Customers
14.4 Dermatology OTC Medications Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us